CIA
MRNA icon

Cape Investment Advisory’s Moderna MRNA Stock Holding History

Cape Investment Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$354 – 819
2025
Q4 		$354 Sell
12
-31
-72% -$842 ﹤0.01% 1265
2025
Q3 		$1.11K Hold
43
– – ﹤0.01% 734
2025
Q2 		$1.19K Hold
43
– – ﹤0.01% 1016
2025
Q1 		$1.22K Hold
43
– – ﹤0.01% 944
2024
Q4 		$1.79K Hold
43
– – ﹤0.01% 893
2024
Q3 		$2.87K Sell
43
-9
-17% -$826 ﹤0.01% 785
2024
Q2 		$6.17K Buy
52
+2
+4% +$253 ﹤0.01% 615
2024
Q1 		$5.33K Sell
50
-655
-93% -$66K ﹤0.01% 641
2023
Q4 		$70.1K Buy
705
+648
+1,137% +$54.5K 0.03% 286
2023
Q3 		$5.89K Buy
57
+33
+138% +$3.68K ﹤0.01% 638
2023
Q2 		$2.92K Buy
+24
New +$3.2K ﹤0.01% 735

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return